Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in ColombiaGlobeNewsWire • 02/13/24
Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)GlobeNewsWire • 01/03/24
Clever Leaves Holdings Inc. Investor Reminder: Robbins LLP is Investigating Clever Leaves Holdings Inc. on Behalf of InvestorsBusiness Wire • 12/07/23
Robbins LLP Reminds Investors it is Investigating Clever Leaves Holdings Inc. on Behalf of ShareholderBusiness Wire • 12/01/23
Calling All Clever Leaves Holdings Inc. (CLVR) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your LossesBusiness Wire • 11/30/23
Clever Leaves to Hold Third Quarter 2023 Conference Call on Thursday, November 9, 2023 at 5:00 p.m. ETGlobeNewsWire • 11/02/23
Clever Leaves Cannabis Operations Declared Carbon Neutral; a First for a Vertically Integrated Medicinal Cannabis CompanyGlobeNewsWire • 08/29/23
Clever Leaves Announces 1-For-30 Reverse Stock Split to Aid Compliance with Nasdaq Listing RequirementsGlobeNewsWire • 08/24/23
Clever Leaves to Hold Second Quarter 2023 Conference Call on Monday, August 14, 2023 at 5:00 p.m. ETGlobeNewsWire • 08/07/23
Colombian Flower Is Now Available To Australian Patients Through Strategic Partnership Between Clever Leaves And Australian Natural Therapeutics GroupGlobeNewsWire • 07/26/23
Clever Leaves Completes Sale of Processing Assets in Portugal to Curaleaf International SubsidiaryGlobeNewsWire • 07/05/23
Clever Leaves and Astrasana Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and SwitzerlandGlobeNewsWire • 05/30/23
Clever Leaves Reminds Shareholders of its Upcoming Annual Meeting on June 2, 2023GlobeNewsWire • 05/26/23